Ratko Djukanovic
Overview
Explore the profile of Ratko Djukanovic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
182
Citations
6485
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jesenak M, Bobcakova D, Bobcakova A, Djukanovic R, Gaga M, Hanania N, et al.
Chest
. 2024 Dec;
PMID: 39672229
Asthma is a common multifaceted respiratory disease with a major impact on quality of life. Despite increased insights into mechanisms underlying various asthma phenotypes and endotypes and the availability of...
2.
Rupani H, Chaudhuri R, Jackson D, Moyses H, Kurukulaaratchy R, Haitchi H, et al.
J Allergy Clin Immunol
. 2024 Nov;
155(1):236-237.
PMID: 39520415
No abstract available.
3.
Khaleva E, Brightling C, Eiwegger T, Altraja A, Begin P, Blumchen K, et al.
Eur Respir J
. 2024 Nov;
PMID: 39510551
Background: We have previously developed Core Outcome Measures sets for Severe Asthma (COMSA) by multi-stakeholder consensus. There are no patient-centred tools to quantify response to biologics for severe asthma. We...
4.
Kermani N, Chung K, Macis G, Santini G, Clemeno F, Versi A, et al.
Eur Respir J
. 2024 Oct;
64(5).
PMID: 39401856
Background: Lung quantitative computed tomography (qCT) severe asthma clusters have been reported, but their replication and underlying disease mechanisms are unknown. We identified and replicated qCT clusters of severe asthma...
5.
Hudson-Colby J, Lewis A, Varkonyi-Sepp J, Ainsworth B, Freeman A, Day A, et al.
Expert Rev Respir Med
. 2024 Sep;
18(10):777-788.
PMID: 39268799
Introduction: Difficult-to-treat asthma is defined as asthma that is uncontrolled despite high-level treatment or requires such treatment to maintain good control and reduce exacerbations. Breathing pattern disorders (BPD) have been...
6.
Jarjour N, Winders T, Hansen A, Akuthota P, Chung K, Durrington H, et al.
J Asthma
. 2024 Sep;
62(2):185-188.
PMID: 39258900
Asthma continues to cause morbidity and mortality despite advances in treatment that include biologics targeting Type 2 inflammation. The International Collaborative Asthma Network (ICAN) forum was developed with the primary...
7.
Versi A, Azim A, Ivan F, I Abdel-Aziz M, Bates S, Riley J, et al.
Eur Respir J
. 2024 Aug;
64(3).
PMID: 39190793
No abstract available.
8.
Versi A, Azim A, Ivan F, I Abdel-Aziz M, Bates S, Riley J, et al.
Clin Transl Med
. 2024 Aug;
14(9):e70007.
PMID: 39187935
Background: Severe asthma (SA) encompasses several clinical phenotypes with a heterogeneous airway microbiome. We determined the phenotypes associated with a low α-diversity microbiome. Methods: Metagenomic sequencing was performed on sputum...
9.
Park S, Fowler S, Shaw D, Adcock I, Sousa A, Djukanovic R, et al.
Allergy Asthma Immunol Res
. 2024 Aug;
16(4):338-352.
PMID: 39155735
Purpose: Asthma is a clinical syndrome with various underlying pathomechanisms and clinical phenotypes. Genetic, ethnic, and geographic factors may influence the differences in clinical presentation, severity, and prognosis. We compared...
10.
Kermani N, Li C, Versi A, Badi Y, Sun K, I Abdel-Aziz M, et al.
Clin Transl Med
. 2024 Jul;
14(7):e1771.
PMID: 39073027
Background: Clustering approaches using single omics platforms are increasingly used to characterise molecular phenotypes of eosinophilic and neutrophilic asthma. Effective integration of multi-omics platforms should lead towards greater refinement of...